Sign in to fuzzto save your conversations, follow your research and come back anytime.
Dipna Pharmachem
SectorHealthcare
| Metric (₹ crore) | Q3 FY25 | Q4 FY25 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|
| Sales | 18.39 | 15.92 | 53.52 | 2.05 |
| Expenses | 17.7 | 14.63 | 51.86 | 1.59 |
| EBITDA | 0.69 | 1.29 | 1.66 | 0.46 |
| Depreciation | 0 | 0 | 0 | 0 |
| EBIT | 0.69 | 1.29 | 1.66 | 0.46 |
| Interest | 0.4 | 0.6 | 0.23 | 0.23 |
| Profit Before Tax | 0.29 | 0.69 | 1.43 | 0.23 |
| Net Profit | 0.14 | 0.5 | 1.04 | 0.18 |
| EPS | 0.06 | 0.21 | 0.4 | 0.07 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.12 | -2.43 | 2.81 | -20.98 | -5.42 | -9.19 |
| Investing Cash Flow | 0.01 | 0 | -0.01 | -0.01 | -0.01 | -0.02 |
| Financing Cash Flow | 3.17 | 2.5 | -2.84 | 26.47 | 13.62 | -4.24 |
| Net Cash Flow | 0.06 | 0.07 | -0.04 | 5.48 | 8.19 | -13.45 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 0.46 | 0.49 | 0.55 | 0.57 | 1.74 | 24.36 | 37.52 | 38.49 |
| Total Liabilities | 10.63 | 13.57 | 17.89 | 24.22 | 34.49 | 53.2 | 95.39 | 93.89 |
| Total Assets | 11.08 | 14.06 | 18.44 | 24.79 | 36.23 | 77.56 | 132.91 | 132.38 |